Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Two Companies Spending Billions to Buy Back Stock
Seeking Alpha
Thursday, February 3, 2011 - 9:50am
tags:
AstraZeneca, stock buyback
Mannkind Shares Popped: What You Need to Know
Motley Fool
Wednesday, February 2, 2011 - 5:22pm
tags:
Afrezza, inhaled insulin, MannKind
Botox, eye drug sales boost Allergan 4Q profit
Yahoo/AP
Wednesday, February 2, 2011 - 5:21pm
tags:
Allergan, profits
Novo Nordisk Q4 profits jump but outlook lowered
Yahoo/AP
Wednesday, February 2, 2011 - 5:18pm
tags:
earnings, Novo Nordisk
Sitting With Pfizer’s New Chief
Forbes
Wednesday, February 2, 2011 - 3:17pm
tags:
Pfizer, Pharma CEOs, Ian Read
Earnings Preview: Merck
Seeking Alpha
Wednesday, February 2, 2011 - 3:14pm
tags:
Merck, earnings
Pfizer & Merck Mega Mergers Disappoint
Minyanville
Wednesday, February 2, 2011 - 3:10pm
tags:
M&A, Pfizer, Merck, Wyeth, Schering Plough
Lilly, Bristol-Myers halt drug study enrollment
Yahoo/AP
Wednesday, February 2, 2011 - 3:09pm
tags:
Eli Lilly, Bristol-Myers Squibb, cancer, necitumumab
Those Pharma Job Cuts Keep Coming, But…
Pharmalot
Wednesday, February 2, 2011 - 12:03pm
tags:
layoffs
FDA Catalyst Trade: Protalix BioTherapeutics
Seeking Alpha
Wednesday, February 2, 2011 - 12:02pm
tags:
FDA, Protalix BioTherapeutics, Pfizer, UPLYSO
Actavis Ordered To Pay $170M For Medicaid Fraud
Pharmalot
Wednesday, February 2, 2011 - 9:10am
tags:
Medicaid, fraud, Actavis
Four Pharma Stocks With Appealing Value, Dividend Yield
Seeking Alpha
Wednesday, February 2, 2011 - 9:08am
tags:
Eli Lilly, Merck, Pfizer, Bristol-Myers Squibb, dividends
Roche Reduces Avastin Forecast as Revenue Declines
Bloomberg
Wednesday, February 2, 2011 - 9:03am
tags:
Roche, Avastin, earnings
Seattle Genetics plans public stock offering
Yahoo/AP
Wednesday, February 2, 2011 - 9:01am
tags:
stock offering, Seattle Genetics
Heart Study Could Cost Twice Orexigen’s Market Cap
Forbes
Wednesday, February 2, 2011 - 8:44am
tags:
Orexigen, obesity, Contrave
Sanofi Diabetes Drug Worked as Well as Byetta in Study
Bloomberg
Wednesday, February 2, 2011 - 8:42am
tags:
Sanofi, diabetes, Byetta, lixisenatide, Amylin, Eli Lilly
GlaxoSmithKline sells stake in Quest for $1.7 bln
Marketwatch
Wednesday, February 2, 2011 - 8:40am
tags:
GSK, Quest
Earnings Preview: Merck to tout pipeline in report
Yahoo/AP
Wednesday, February 2, 2011 - 8:40am
tags:
Merck, earnings
Generic Risk Looms over Endo Pharma
Yahoo/Zacks.com
Tuesday, February 1, 2011 - 9:18pm
tags:
generics, Endo, Mylan, lidoderm
Analysts: Genzyme may fetch $77 a share
Bizjournals.com
Tuesday, February 1, 2011 - 9:15pm
tags:
Genzyme, Sanofi, M&A

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.